Aspire Private Capital’s DexCom DXCM Stock Holding History

Aspire Private Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-84	Closed	-$5.63K	–	294
2024 Q3	$5.63K	Hold	84	–	–	﹤0.01%	450
2024 Q2	$9.52K	Hold	84	–	–	﹤0.01%	391
2024 Q1	$11.7K	Hold	84	–	–	﹤0.01%	385
2023 Q4	$10.4K	Hold	84	–	–	﹤0.01%	385
2023 Q3	$7.84K	Hold	84	–	–	﹤0.01%	427
2023 Q2	$10.8K	Hold	84	–	–	﹤0.01%	373
2023 Q1	$9.76K	Hold	84	–	–	﹤0.01%	371
2022 Q4	$9.51K	Hold	84	–	–	﹤0.01%	365
2022 Q3	$7K	Hold	84	–	–	﹤0.01%	383
2022 Q2	$6K	Hold	84	–	–	﹤0.01%	378
2022 Q1	$11K	Hold	84	–	–	﹤0.01%	335
2021 Q4	$11K	Hold	84	–	–	﹤0.01%	328
2021 Q3	$11K	Buy	+84	New	+$10.6K	﹤0.01%	306
2021 Q1	–	Sell	-84	Closed	-$8K	–	548
2020 Q4	$8K	Hold	84	–	–	﹤0.01%	276
2020 Q3	$9K	Buy	+84	New	+$8.78K	﹤0.01%	274

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Aspire Private Capital's DXCM Position: Q4 2024 in Review

Aspire Private Capital sold out of DexCom (DXCM) in Q4 2024, closing a stake of 84 shares — an estimated $5.63K sold.

Aspire Private Capital first reported a position in DXCM in Q3 2020 and held it in 15 quarters. The position peaked at $11.7K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Aspire Private Capital reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 84 DexCom shares in Q4 2024, an estimated $5.63K.
Aspire Private Capital first reported a position in DexCom in Q3 2020 and held it in 15 quarters.
Aspire Private Capital's DexCom position peaked at $11.7K in Q1 2024.
950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.